Trials / Completed
CompletedNCT01594294
An Evaluation of Marketed Contact Lens Disinfectant Systems on Eyelid Tissues
EVALUATION OF THE EFFECTS OF CLEAR CARE® / AOSEPT® PLUS HYDROGEN PEROXIDE SOLUTION ON THE EYELID TISSUES - Part III: COMPARATIVE EVALUATION WITH RENU® MPS OVER 3 MONTH OF WEAR - CONTROL EVALUATION WITH AIR OPTIX® AQUA and ACUVUE® 2®
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to assess and compare the effect of the repeated usage of 2 different care systems (one hydrogen peroxide based cleaning and disinfecting system and one PHMB containing multipurpose system) with ACUVUE® 2® and AIR OPTIX® AQUA contact lenses worn on a daily wear basis for a 3-month period.
Detailed description
This study was divided into 2 periods, a Screening Phase and an Investigational Phase. During the Screening Phase, subjects were fitted and dispensed with either ACUVUE® 2® (for current hydrogel wearers) or AIR OPTIX® AQUA (for current silicone hydrogel wearers) contact lenses and used COMPLETE® MPS Easy Rub® Formula to clean and disinfect their lenses. At the completion of the Screening Phase, the symptomatic status of the subjects was re-assessed. Those subjects who qualified proceeded to the Investigational Phase and were dispensed with new pair of study contact lenses identical to the lenses they wore during the Screening Phase to use in conjunction with the allocated study care product, CLEAR CARE® /AOSEPT® Plus or ReNu MultiPlus®.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | AOSEPT® Plus contact lens solution | Hydrogen peroxide-based cleaning and disinfection system |
| DEVICE | ReNu MultiPlus® contact lens solution | Polyaminopropyl biguanide (PHMB) preserved multipurpose solution |
| DEVICE | Etafilcon A contact lenses | Hydrogel contact lenses worn on a daily wear basis for 14 days (Screening Phase) and 3 months (Investigational Phase). During the Investigational Phase, the contact lenses lenses were worn a minimum of six hours per day, 5 days per week, with a fresh pair dispensed every 2 weeks. |
| DEVICE | Lotrafilcon B contact lenses | Silicone hydrogel contact lenses worn on a daily wear basis for 30 days (Screening Phase) and 3 months (Investigational Phase). During the Investigational Phase, the contact lenses lenses were worn a minimum of six hours per day, 5 days per week, with a fresh pair dispensed monthly. |
| DEVICE | COMPLETE® MPS Easy Rub® Formula contact lens solution | PHMB 0.0001% and poloxamer 0.05% multipurpose solution |
Timeline
- Start date
- 2012-04-01
- Primary completion
- 2013-06-01
- Completion
- 2013-06-01
- First posted
- 2012-05-09
- Last updated
- 2014-07-25
- Results posted
- 2014-07-25
Source: ClinicalTrials.gov record NCT01594294. Inclusion in this directory is not an endorsement.